Clinical Trials

NCT05206422 | COMPLETED | NA
21 participants

DORAYA-HF Early Feasibility Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-13
Start Date:
2022-10-05
Completion:
2026-01-31
Conditions
  • Acute Decompensated Heart Failure
Interventions
  • DEVICE
No Results Yet
NCT05198830 | RECRUITING | PHASE2
42 participants

Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-13
Start Date:
2022-12-15
Completion:
2027-06-30
Conditions
  • Lung Adenocarcinoma
  • Lung Large Cell Carcinoma
  • Lung Non-Squamous Non-Small Cell Carcinoma
  • Stage III Lung Cancer AJCC v8
Interventions
  • DRUG
  • PROCEDURE
  • BIOLOGICAL
  • RADIATION
No Results Yet
NCT05198284 | ACTIVE_NOT_RECRUITING
2000 participants

Prospective Decision Impact Clinical Utility Trial of KidneyIntelX

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-13
Start Date:
2021-11-01
Completion:
2023-12-01
Conditions
  • Diabetic Kidney Disease
  • Chronic Kidney Diseases
  • Chronic Kidney Disease Stage 1
  • Chronic Kidney Disease Stage 2
  • Chronic Kidney Disease Stage 3
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
NCT05136196 | RECRUITING | PHASE2
150 participants

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-13
Start Date:
2022-12-06
Completion:
2027-01-01
Conditions
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • Locally Recurrent Head and Neck Squamous Cell Carcinoma
  • Locally Recurrent Hypopharyngeal Squamous Cell Carcinoma
  • Locally Recurrent Laryngeal Squamous Cell Carcinoma
  • Locally Recurrent Oral Cavity Squamous Cell Carcinoma
  • Locally Recurrent Oropharyngeal Squamous Cell Carcinoma
  • Metastatic Head and Neck Squamous Cell Carcinoma
  • Metastatic Hypopharyngeal Squamous Cell Carcinoma
  • Metastatic Laryngeal Squamous Cell Carcinoma
  • Metastatic Melanoma
  • Metastatic Oral Cavity Squamous Cell Carcinoma
  • Metastatic Oropharyngeal Squamous Cell Carcinoma
  • Recurrent Melanoma
  • Stage III Hypopharyngeal Carcinoma AJCC v8
  • Stage III Laryngeal Cancer AJCC v8
  • Stage III Lip and Oral Cavity Cancer AJCC v8
  • Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8
  • Stage IV Hypopharyngeal Carcinoma AJCC v8
  • Stage IV Laryngeal Cancer AJCC v8
  • Stage IV Lip and Oral Cavity Cancer AJCC v8
  • Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8
  • Unresectable Melanoma
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT04960514 | ACTIVE_NOT_RECRUITING
2000 participants

Prospective Decision Impact Trial of KidneyIntelX

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-13
Start Date:
2021-11-22
Completion:
2023-12-01
Conditions
  • Diabetic Kidney Disease
  • Chronic Kidney Disease Stage 1
  • Chronic Kidney Disease Stage 2
  • Chronic Kidney Disease, Stage 3 (Moderate)
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
NCT04930653 | SUSPENDED | PHASE2
34 participants

Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-13
Start Date:
2022-10-19
Completion:
2028-06-15
Conditions
  • Folliculotropic Mycosis Fungoides
  • Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
  • Sezary Syndrome
  • Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8
  • Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8
  • Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8
  • Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8
  • Transformed Mycosis Fungoides
Interventions
  • PROCEDURE
  • BIOLOGICAL
  • OTHER
No Results Yet
NCT04912739 | RECRUITING
18000 participants

Targeted Health Dialogues in Primary Care

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-13
Start Date:
2020-10-01
Completion:
2030-12-31
Conditions
  • Health Behaviors
  • Risk Factors
  • Cardiovascular Diseases
  • Cancer
  • Serious Diseases
Interventions
  • BEHAVIORAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page